是否到了探讨降压药减用时机和方法的时候？

参考文献

[1] Bahrainwala JZ, Bhalla V . The role of mineralocorticoid receptors in the treatment of primary hypertension[J]. Curr Hypertens Rep, 2026, 28(1): 7.

[2] Takeda Y, Demura M, Yoneda T, et al. Epigenetic regulation of the renin-angiotensin-aldosterone system in hypertension[J]. Int J Mol Sci, 2024, 25(15): 8099.

[3] Aranda-Lara P, Martínez-Esteban MD, Muñoz JJ, et al. Renal sympathetic denervation: a new treatment strategy in the management of refractory arterial hypertension[J]. Nefrologia, 2012, 32(5): 555-557.

[4] 中国高血压防治指南修订委员会, 高血压联盟 (中国), 中国医疗保健国际交流促进会高血压病学分会, 等 . 中国高血压防治指南 (2024 年修订版)[J]. 中华高血压杂志（中英文）, 2024, 32(7): 603-673.

[5] 中国心胸血管麻醉学会非心脏手术麻醉分会 . 心脏病患者非心脏手术围麻醉期中囯专家临床管理共识 (2020)[J]. 麻醉安全与质控, 2021, 5(2): 63-77.

[6] 刘海伦, 周婧彧, 郑静静, 等 . 高血压新药物治疗研究进展[J]. 中华高血压杂志, 2023, 31(11): 1117-1123.

[7] 中华医学会内分泌学分会 . 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识 (2020 版)[J]. 中华内分泌代谢杂志, 2020, 36(9): 737-750.

[8] 中国心脏联盟心血管疾病预防与康复专业委员会 . 高血压患者血压季节变化临床管理中国专家共识[J]. 中华高血压杂志, 2022, 30(9): 813-817.

[9] Charchar FJ, Prestes PR, Mills C, et al. Lifestyle management of hypertension: Internation Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension[J]. J Hypertension, 2024, 42(1): 23-49.

[10] Benetos A, Gautier S, Freminet A, et al. Reduction of antihypertensive treatment in nursing home residents[J]. N Engl J Med, 2025, 393(20): 1990-2000.

[11] Kraut RY, Youngson E, Sadowski CA, et al. Antihypertensive deprescribing in frail long-term care residents (OptimizeBP): protocol for a prospective, randomised, open-label pragmatic trial[J]. BMJ Open, 2024, 14(8): e084619.